论文部分内容阅读
在常规治疗的基础上,我们应用抗栓酶-3号治疗肺心病急性加重期23例并与对照组23例进行血液流变学的对比。
On the basis of routine treatment, we applied antithrombin-3 for the treatment of 23 cases of acute exacerbation of pulmonary heart disease and compared with the control group of 23 cases for hemorheology.